Literature DB >> 8172142

Delayed gastric emptying of both the liquid and solid components of a meal in chronic liver disease.

J S Galati1, K P Holdeman, G V Dalrymple, K A Harrison, E M Quigley.   

Abstract

OBJECTIVES: To evaluate gastric emptying in patients with chronic liver disease and portal hypertension.
METHODS: We measured gastric emptying of both the liquid and solid components of a meal in 10 consecutive patients with chronic liver disease and portal hypertension, but free of ascites, and 14 age- and sex-matched healthy controls. In the patients with liver disease, relationships between emptying and liver function were examined. To measure gastric emptying, subjects consumed a test meal that consisted of scrambled eggs labeled with 99mTc-sulfur colloid and 4 oz of water labeled with 111In-diethylene triamine pentacetic acid (DTPA).
RESULTS: Patients with liver disease and portal hypertension demonstrated delayed emptying of both the liquid (t1/2, min, mean +/- SE, patients vs. CONTROLS: 69.4 +/- 19.4 vs. 31.4 +/- 1.8, p < 0.01) and solid (post-lag phase solid emptying: 141 +/- 32.9 vs. 69.8 +/- 4.6, p < 0.006) components of the meal. We could not identify any correlation between gastric emptying and tests of liver function.
CONCLUSIONS: Gastric emptying is delayed in patients with liver disease and portal hypertension; this abnormal gastric motor function may contribute to the pathophysiology of foregut complaints in this patient population.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8172142

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  18 in total

1.  Preservation of the left gastric vein in delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy.

Authors:  Isao Kurosaki; Katsuyoshi Hatakeyama
Journal:  J Gastrointest Surg       Date:  2005 Jul-Aug       Impact factor: 3.452

Review 2.  Alcoholic liver disease and malnutrition.

Authors:  Craig J McClain; Shirish S Barve; Ashutosh Barve; Luis Marsano
Journal:  Alcohol Clin Exp Res       Date:  2011-02-01       Impact factor: 3.455

3.  Fixation of the round ligament to the peritoneum and wrapping of the cut surface of the liver for prevention of early delayed gastric emptying after hepatic lateral segmentectomy.

Authors:  Takatsugu Oida; Kenji Mimatsu; Atsushi Kawasaki; Hisao Kanou; Youichi Kuboi; Sadao Amano
Journal:  Langenbecks Arch Surg       Date:  2008-12-20       Impact factor: 3.445

Review 4.  Gut microbiota: its role in hepatic encephalopathy.

Authors:  Rahul Rai; Vivek A Saraswat; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-12-16

Review 5.  Gastroparesis: pathogenesis, diagnosis and management.

Authors:  William L Hasler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-19       Impact factor: 46.802

Review 6.  Gastrointestinal dysfunction in liver disease and portal hypertension. Gut-liver interactions revisited.

Authors:  E M Quigley
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

7.  First pass metabolism of ethanol is strikingly influenced by the speed of gastric emptying.

Authors:  C M Oneta; U A Simanowski; M Martinez; A Allali-Hassani; X Parés; N Homann; C Conradt; R Waldherr; W Fiehn; C Coutelle; H K Seitz
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

8.  Abnormal gastric motility in liver cirrhosis: roles of secretin.

Authors:  A Usami; Y Mizukami; M Onji
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

9.  Gastric myoelectrical activity in patients with primary biliary cirrhosis.

Authors:  Anna Kasicka-Jonderko; Beata Krusiec-Swidergoł; Krzysztof Jonderko; Joanna Musialik; Maciej Gonciarz; Barbara Błońska-Fajfrowska; Zbigniew Gonciarz
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

10.  A disturbance of the gastric myoelectric activity in post-operative patients with biliary atresia.

Authors:  Masahiro Ohtaki; Minoru Yagi; Masayuki Kubota; Shinji Homma
Journal:  Pediatr Surg Int       Date:  2004-01-14       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.